Prevention of indomethacin-induced intestinal ulcers by various catatoxic steroids.
D000305:Adrenal Cortex Hormones / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000992:Antitoxins / Q000494:pharmacology / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003345:Corticosterone / Q000627:therapeutic use; D005032:Ethylestrenol / Q000627:therapeutic use; D005260:Female; D007213:Indomethacin; D007410:Intestinal Diseases / Q000139:chemically induced / Q000517:prevention & control*; D009654:Norsteroids / Q000627:therapeutic use; D010074:Oxandrolone / Q000627:therapeutic use; D010538:Peritonitis / Q000517:prevention & control; D011239:Prednisolone / Q000627:therapeutic use; D011277:Pregnanediones / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use; D051381:Rats; D013148:Spironolactone / Q000627:therapeutic use; D014221:Triamcinolone / Q000627:therapeutic use; D014456:Ulcer / Q000517:prevention & control
D000305:Adrenal Cortex Hormones; D000992:Antitoxins; D009654:Norsteroids; D011277:Pregnanediones; D014221:Triamcinolone; D013148:Spironolactone; D011374:Progesterone; D010074:Oxandrolone; D011239:Prednisolone; D005032:Ethylestrenol; D003345:Corticosterone; D007213:Indomethacin